Thomas J. Manley, MD

He also works as a clinician on the Seattle Children’s Hospital sarcoma team.Dana C. Matthews, MD, is director of clinical hematology at Seattle Children’s Hospital and head of the Pediatric Hemophilia Program; she is associate professor at the University of Washington School of Medicine. Her research interests include risk-based optimization of the treatment of pediatric thrombosis, and clinical outcomes in patients with hemophilia. In particular, she is participating in a project to characterize immune responses to factor VIII that result in inhibiting antibodies that significantly complicate the management of hemophilia A, and a prospective study of the development of inhibitors in young patients with hemophilia. Additionally, she is interested in improving the outcome for pediatric patients with thrombosis by developing a pediatric thrombosis registry and developing clinical trials for subgroups of patients with thrombosis. She is a member of the board of directors for the American Thrombosis and Hemostasis Network, a national organization with the mission to “provide stewardship in the development and support of an accessible national database to support excellence in patient care, research, professional mentorship, and public health translation.” She is a member of the hematology-oncology subboard of the American Board of Pediatrics, and will chair that subboard for two years beginning in late 2007.